Animal immune function assessment is a systematic, standards-based evaluation of humoral, cellular, and innate immune responses in laboratory and target animal species. Accredited third-party laboratories use validated in vivo and in vitro assays to substantiate immunomodulatory claims for feed additives, pet food ingredients, veterinary products, and functional bioactive compounds. This article outlines the sample types, testing parameters, analytical methods, and typical applications of professional animal immune function evaluation.
Technical Overview
Animal immune function assessment refers to the systematic measurement of immune competence in animals using a battery of standardized in vivo, ex vivo, and in vitro assays. It quantifies how a test substance—such as a feed additive, nutraceutical, probiotic, plant extract, or veterinary preparation—affects humoral immunity (antibody-mediated), cellular immunity (T-cell-mediated), and innate or non-specific immunity (phagocytes, natural killer cells, complement). The results support product efficacy claims, immunotoxicity screening, vaccine and adjuvant development, and regulatory dossiers.
A typical study is conducted in healthy laboratory animals (commonly mice or rats) or in the target species (poultry, swine, ruminants, aquatic species, or companion animals). Animals are assigned to control, low-, medium-, and high-dose groups, often with a positive control group, and receive the test substance orally for 28 to 90 days. Immune endpoints are then measured in serum, whole blood, and immune organs such as the thymus, spleen, and lymph nodes.
Studies are performed by accredited third-party laboratories operating under ISO/IEC 17025 quality management systems and, where applicable, Good Laboratory Practice (GLP) principles. Animal housing, husbandry, and microbiological monitoring follow recognized laboratory animal standards such as the GB 14925 and GB/T 14926 series, and all protocols are subject to institutional animal ethics review in line with the 3Rs principles (replacement, reduction, and refinement).
Testing Samples
Test Substances
Immune function studies commonly evaluate functional feed additives (probiotics, prebiotics, synbiotics, and postbiotics), yeast and fungal derivatives such as beta-glucans and mannan oligosaccharides, plant and herbal extracts, small peptides, nucleotides, organic trace minerals, vitamins, fermented products, finished pet foods, and veterinary immunostimulant or vaccine adjuvant candidates.
Biological Specimens
Collected specimens include serum and plasma for immunoglobulin and cytokine quantification; heparinized whole blood for lymphocyte subset phenotyping; thymus, spleen, mesenteric lymph nodes, and Peyer's patches for cell isolation, organ index calculation, and histopathology; peritoneal macrophages for phagocytosis assays; intestinal contents and lavage fluid for secretory IgA; and bronchoalveolar lavage fluid for mucosal immunity endpoints.
Experimental Animal Models
Standard models include specific-pathogen-free (SPF) mice and rats—such as BALB/c, Kunming, ICR, C57BL/6, Sprague-Dawley, and Wistar strains—for the full mechanistic test battery. Target-species trials in broilers, layers, piglets, calves, fish, shrimp, dogs, and cats are used for translational validation under realistic feeding conditions.
Testing Items
Core testing items are organized into four complementary categories:
- General indicators: body weight, feed intake, thymus index and spleen index (immune organ-to-body-weight ratios), peripheral leukocyte and differential counts, and histopathology of immune organs.
- Humoral immunity: serum IgG, IgM, and IgA by immunoassay; antigen-specific antibody titers (for example, against sheep red blood cells or ovalbumin); serum hemolysin level (HC50); antibody plaque-forming cell (PFC) response; and B-lymphocyte proliferation induced by LPS.
- Cellular immunity: T-lymphocyte proliferation induced by concanavalin A (ConA); delayed-type hypersensitivity (DTH) response; T-cell subsets (CD3+, CD4+, CD8+, and CD4+/CD8+ ratio) by flow cytometry; and T-cell-related cytokines such as IL-2, IL-4, IFN-γ, and IL-6.
- Innate and mucosal immunity: macrophage phagocytic rate and phagocytic index; carbon particle clearance index; natural killer (NK) cell activity; serum lysozyme activity; complement activity (CH50); nitric oxide production; and intestinal or bronchial secretory IgA.
Additional endpoints include pro-inflammatory and regulatory cytokine panels (TNF-α, IL-1β, IL-10, TGF-β), oxidative stress markers relevant to immune performance (superoxide dismutase, glutathione peroxidase, and malondialdehyde), and immunotoxicity indicators such as hypersensitivity responses and autoantibody screening for safety evaluation programs.
Testing Methods
Humoral Immunity Assays
Serum immunoglobulins and antigen-specific antibody titers are quantified by indirect ELISA and hemagglutination assays. The hemolysin assay measures complement-mediated lysis of sensitized sheep red blood cells to derive the HC50 value, while the plaque-forming cell assay enumerates antibody-secreting splenocytes.
Cellular Immunity Assays
Splenocyte or peripheral blood lymphocyte proliferation is measured by MTT or CCK-8 colorimetric assays following ConA or LPS stimulation. Delayed-type hypersensitivity is evaluated as ear or footpad swelling after antigen challenge, and T-lymphocyte subsets are profiled by multicolor flow cytometry using fluorescent monoclonal antibodies.
Innate Immunity Assays
Macrophage phagocytosis is assessed ex vivo using chicken red blood cells, and the carbon clearance test quantifies mononuclear phagocyte system activity in vivo. NK cell cytotoxicity is measured by LDH release assays or flow-cytometric target-cell killing assays against sensitive target cells such as YAC-1 or K562.
Molecular and Analytical Platforms
Cytokines are quantified by sandwich ELISA or multiplex bead-based assays; immune-related gene expression (for example, IFN-γ, IL-2, TNF-α, and sIgA-associated genes) is analyzed by real-time quantitative PCR; protein expression is confirmed by western blotting and immunohistochemistry; and immune organ morphology is evaluated by standardized histopathological staining.
Data are analyzed statistically across dose groups against controls. Under widely adopted functional evaluation criteria, an immune-enhancing effect is generally substantiated when significant, dose-related positive results are observed in at least two of the four immune categories—cellular immunity, humoral immunity, mononuclear phagocyte function, and NK cell activity—without adverse effects on body weight, organ indices, or general health.
Applications
- Efficacy substantiation for immune-support claims on feed additives, premixes, and functional pet food formulations.
- Registration dossiers and scientific substantiation files for probiotics, botanical extracts, and bioactive ingredients.
- Adjuvant and immunostimulant screening during veterinary vaccine development.
- Aquaculture health programs evaluating immunostimulants for disease resistance in fish and shrimp.
- Immunotoxicity and safety screening of chemicals, residues, and novel ingredients in line with toxicological evaluation programs such as the GB 15193 series.
- Academic and industrial research supporting peer-reviewed publications on immunomodulation mechanisms.
FAQ
Which animal species are used for immune function assessment?
SPF mice and rats are the standard models for the full mechanistic test battery because their immune endpoints are well characterized. Target-species studies in poultry, swine, aquatic animals, dogs, and cats are subsequently used to confirm translational relevance under real feeding conditions.
How long does a typical study take?
Most oral feeding studies run 30 to 45 days, plus acclimatization and antigen immunization windows. Complex protocols involving multiple challenges or recovery phases may extend to 60 to 90 days, and laboratory scheduling typically adds two to four weeks for animal preparation and report issuance.
How many animals are required per group?
Common designs use 10 to 20 animals per group, depending on the endpoint battery and statistical power requirements, subject to ethics committee approval and 3Rs-based animal reduction principles.
What result is needed to claim immune enhancement?
Under widely applied functional evaluation criteria, significant and dose-related positive results are required in at least two of the four immune categories—cellular immunity, humoral immunity, mononuclear phagocyte function, and NK cell activity—without adverse effects on body weight, organ indices, or overall health status.
Can testing be performed directly on the target species?
Yes. Species-specific panels measuring serum immunoglobulins, vaccine antibody titers, lymphocyte subsets, cytokines, and phagocyte activity are available for poultry, swine, ruminants, fish, and companion animals, supporting both research trials and commercial product validation.
